Mucopolysaccharidosis (MPS) Treatment Market To Surpass US$ 3,014.9 Million By 2027 - Coherent Market Insights

1. MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Mucopolysaccharidosis (MPS) Treatment Market - Overview Global Mucopolysaccharidosis (MPS) Treatment Market, By Treatment (Enzyme Replacement Therapy and Stem Cell Therapy ), By MPS Type (MPS-I, MPS-II, MPS-IV, MPS-VI, MPS-VII, and Others (MPS-III and MPS-IX)), By End User (Hospitals, Specialty Clinics, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,566.5 million in 2020 and is expected to exhibit a CAGR of 9.8% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. The companies are focusing on adoption of inorganic growth strategies such as collaboration and acquisition, in order to expand their product portfolio and strengthen their presence in the market, which is expected to drive growth of the mucopolysaccharidosis (MPS) treatment market over the forecast period. For instance, on August 11, 2020, Sarepta Therapeutics Inc. and the University of Florida announced a strategic collaboration to enable cutting-edge research for novel genetic medicines for the treatment of rare genetic diseases such as mucopolysaccharidosis. For instance, in July 2020, Abeona Therapeutics Inc. announced that two ongoing MPS III Phase 1/2 clinical trials of its investigational adeno-associated virus (AAV)-based gene therapies, ABO-102 and ABO-101, have showed positive effects on the patients, with additional enrollment expected in the programs in the coming weeks. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/mucopolysaccharidosis-treatment-market-4184 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Moreover, governments are taking various initiatives to combat COVID-19. For instance, in May 2020, the Centers for Disease Control and Prevention started working with the All-of- Government and All-of-America Approach to increase testing capacity and availability to improve case detection and contact tracing though all states in the U.S., and plans to re-open America by removing the lockdown. Browse 35 Market Data Tables and 34 Figures spread through 198 Pages and in-depth TOC on “Mucopolysaccharidosis (MPS) Treatment Market”- Global Forecast to 2027, By Treatment (Enzyme Replacement Therapy and Stem Cell Therapy), By MPS Type (MPS-I, MPS-II, MPS-IV, MPS-VI, MPS-VII, and Others (MPS-III and MPS-IX)), By End User (Hospitals, Specialty Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa). Key players operating in the market are providing special reimbursement package for patients. For instance, Takeda Pharmaceutical Company Limited initiated Takeda OnePath Assistance Program, which offers personalized support to the patients. The program takes care of patients by making medicines available to the patients for their treatment, which are manufactured by Takeda Pharmaceutical Company Limited. The program also provides insurance in order to cover the expense of the patients’ treatment. The program also supports patients suffering from Hunter Syndrome (MPS II). Thus, providing reimbursements increase the customer base, which strengthens the position of the company in the global market. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4184 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Global Mucopolysaccharidosis (MPS) Treatment Market: The global mucopolysaccharidosis (MPS) treatment market is expected to exhibit a CAGR of 9.8% over the forecast period, owing to increasing agreements and acquisitions by market players. For instance, on August 11, 2020, Sarepta Therapeutics Inc. and the University of Florida announced a strategic collaboration to enable cutting-edge research for novel genetic medicines for the treatment of rare genetic diseases such as mucopolysaccharidosis. Among treatment, the enzyme replacement therapy segment held a dominant position in the mucopolysaccharidosis (MPS) treatment market in 2019, owing to increasing approval for enzyme replacement therapy for mucopolysaccharidosis (MPS) treatment. For instance, in October 2018, Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, received Brazil’s National Health Surveillance Agency (ANVISA) approval for its Mepsevii (vestronidase alfa) for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome) for patients of all ages. Key players operating in the global mucopolysaccharidosis (MPS) treatment market include Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics Inc., Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Therapeutics, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd. Inc., Ultragenyx Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4184 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved